Acquisition of Life Science Lab Space at Cambridge Crossing

United States

Deal value: $95,000,000

Alexandria Real Estate Equities acquired a 120,000 sq ft life science lab building at Cambridge Crossing, Boston, MA, targeting biotech and pharmaceutical tenants.

Alexandria Real Estate Equities is acquiring life science lab space at Cambridge Crossing to strengthen its position in Boston’s premier biotech cluster. The investment is driven by sustained demand from biotech and pharmaceutical tenants seeking high-quality, purpose-built lab facilities. The timing reflects confidence in the resilience of life sciences, the strategic value of Cambridge Crossing, and Alexandria’s belief in long-term rental growth and asset appreciation in core innovation markets.